Menlo Ventures published a report showing that the healthcare industry is the leading adopter of AI - one of the co-authors shares the key takeaways

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BIO-Europe 2025: Spain based ARTHEx Biotech is a European player in the DM1 space, and believes its microRNA strategy offers a dual benefit that it says is unique to the field

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BIO-Europe 2025: Sparrow Pharmaceuticals raised a $95M series B last month - it will be testing its cortisol depleting HSD1 inhibitor in type 2 diabetes

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BIO-Europe 2025: Topas Therapeutics is delivering nanoparticles to the liver to establish tolerance in T-cells for autoimmune and immune-mediated disease - it recently had intriguing data in celiac

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BIO-Europe 2025: Step Pharma has 'followed the genetics' to be the first company to target CTPS1 inhibition for cancer - CEO Andrew Parker walks us through this unique science

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BIO-Europe 2025: Barcelona based Connecta Therapeutics is moving its neuroplasticity modulator for fragile X syndrome into a phase 2a study after completing first in human studies late last year

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BIO-Europe 2025: Switzerland based ReproNovo is focused on reproductive health - with two clinical stage assets and three indications it is going after

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BIO-Europe 2025: Anavo Therapeutics is focused on phosphatases - and is publicly talking about its two lead programs for the first time

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BIO-Europe 2025: Herantis Pharma is developing HER-096 for Parkinson's, a blood-brain-barrier penetrant small peptide molecule that is designed to mimic the activity of CDNF

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BIO-Europe 2025: Valneva's partner Pfizer has been running a big trial of a Lyme disease vaccine that has covered the last three seasons - it will read out in the first part of next year

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Roche will pay Manifold Bio $55M up front, and up to $2B in biobucks, to collaborate on multiple next-generation brain shuttles for neurological diseases

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BIO-Europe 2025: ReNewVax CEO Neil Murray believes the antigens the company has found will enable it to develop a pneumococcal vaccine that targets all ca.100 existing variants

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BIO-Europe 2025: Abivax CEO Marc de Garidel discusses physician and payor feedback after obefazimod's phase 3 UC induction readouts, and next steps regarding maintenance and Crohn's

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BIO-Europe 2025: AAVantgarde Bio, which is working on gene therapies for inherited retinal diseases that are caused by mutations in large genes, closed a $141M series B raise today

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Mathai Mammen recaps the first clinical data Parabilis Medicines reported on its beta-catenin program earlier this month at EMSO and AACR-NCI-EORTC 2025. Plus, degraders for prostate cancer, and more.

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BiotechTV visited South San Francisco based Noetik and saw how they are digitizing tumor samples and using AI to sort through the complexity of the biology for drug discovery

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Sonoma Biotherapeutics announced early clinical data today in a late-breaker at #ACR25 for its CAR-Treg to treat rheumatoid arthritis. Co-Founders Jeff Bluestone and Fred Ramsdell walk us through it.

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Zag Bio launched today with $80M, and aims to tackle autoimmune disease by using antibodies to reprogram how Tregs and Teffs are created in the thymus. The lead indication will be Type 1 diabetes

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Hemab Therapeutics, a company specializing in developing treatments for bleeding disorders, announced a $157 million series C raise today. CEO Benny Sorensen describes the work and unmet need.

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Weave Bio, which raised a $20M series A this month, is aiming to use software and LLMs to automate and streamline regulatory submissions for drug development

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Ahead of a year of increased clinical activity, Entrada Therapeutics' CEO Dipal Doshi discusses the company's EEV platform, DMD programs, and a Vertex partnership in DM1

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Disc Medicine CEO John Quisel describes the process of becoming among the first companies to receive FDA's new Commissioner's National Priority Voucher (CNPV)

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Biotech entrepreneurs share advice on navigating through today's uncertain times: "It's going to be okay"

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Flagship Pioneering announced its newest company to emerge out of stealth mode today: Expedition Medicines. It is leveraging generative design for small molecule covalent chemistry

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Biotech veteran Oz Azam has become the CEO of Cue Biopharma. He walks us through the science behind the company's new focus in autoimmune that has him excited about the opportunity

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Get to know Women In Bio, and how this organization helps women at all stages of their careers in biotech

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Emeryville, CA based Profusa is developing an injectable biosensor that aims to generate biochemistry information for users in real time

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

PepGen's CEO James McArthur gives an overview of the company's recent data in myotonic dystrophy type 1, which showed a mean splicing correction of 53.7% at the 15 mg/kg dose

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Benchtalk 2025: Kate Haviland discusses the $9B+ acquisition of Blueprint by Sanofi, being chair of Fulcrum, her thoughts on M&A, and what is interesting in biotech today

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Benchtalk 2025: Generate:Biomedicines' VP of Informatics Stephen Kottmann describes the investments in technology that ensures only the highest quality data returns back into its models

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Benchtalk 2025: Benchling Co-Founder & CEO Sajith Wickramasekara describes why he believes science and Benchling are entering a new era of speed and cost of R&D

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Benchtalk 2025: Dyne Therapeutics' CSO Ron Batra describes the company's FORCE platform, and previews big trial scheduled in DMD and DM1 over the next year

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Sunrise Group, which has designed a mandibular sensor for at-home diagnosis of sleep apnea, recently raised $29M to expand its digital sleep clinic that patients can access remotely

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Oxford's OrganOx became one of the UK's biggest news stories when it was announced it would be acquired by Japan's Terumo for approximately $1.5 billion - here's the revolutionary technology behind it

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Oxford, UK based OMass Therapeutics, experts in the use of mass spectrometry in drug development, recently landed a $20M up front licensing deal with Roche on one of its preclinical candidates for IBF

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

NYSE Market Strategist Eric Criscuolo discusses biotech's newfound momentum and whether it might attract generalists to take a look at the sector

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Immuneering's CEO walks us through the company's MEK data in pancreatic cancer, and explains the science behind 'deep cyclic inhibition'

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

R.W. Baird Managing Director & Senior Biotech Analyst Brian Skorney discusses numerous battleground companies in biotech

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Biotech veteran David Hung talks about the launch of IBTROZI in ROS1 positive non-small cell lung cancer, and what's next for Nuvation Bio

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Complement Therapeutics received IND clearance from U.S. FDA today to start a trial of its AAV gene therapy for geographic atrophy that delivers a truncated version of Complement Receptor 1 to the eye

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Align Summit: Cambridge based Quiver Bioscience is developing ASOs for CNS conditions, including having programs in the red hot Nav1.7/1.8 pain space

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Align Summit: Toronto based HDAX Therapeutics believes there are many indications to tackle with its dual binding approach to HDAC6

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Align Summit: Allston based KiraGen Bio is aiming to program CAR-T cells to tune out the suppressive nature of the tumor micro environment. The first program will be for GBM.

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Soufflé Therapeutics exited stealth today with the goal of developing nucleic acid therapies, like siRNAs and ASOs, delivered to any cell in the body by targeting internalizing receptors

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Brian Alexander, former CEO of Foundation Medicine, describes how Valo Health is using its AI expertise to partner with companies and foundations on discovery and development projects

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Aerska launched in the UK today with $21M in financing to develop RNAi medicines for neurological conditions that are delivered to the brain via 'brain shuttle' technologies across the BBB

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Enanta Pharmaceuticals' CEO and CMO discuss data announced today on the company's RSV treatment, Zelicapavir, and describe the road ahead for this program and the company

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Sunny Kumar, a partner at Informed Ventures, and an active investor in the AI space, talks about current and future implications of AI's impact on healthcare

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Eko Health's Co-Founder & CEO shows BiotechTV the company's digital stethoscope and explains how having both an electric and sound component can help physicians catch heart disease (and more) earlier

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Sweden's Annoca announced a $46M raise last month to help move its first TCR-T program into the clinic for KRAS-driven pancreatic cancer. CEO Reagan Jarvis tells us about that work and more.

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Xspray Pharma makes protein kinase inhibitors that are amorphous, and therefore more soluble than current products. Dasynoc, its version of dasatinib (Sprycel), is in front of FDA with an Oct 7 PDUFA

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Pareto Securities Healthcare Conference: Egetis Therapeutics has a therapy for a rare disease called MCT8 deficiency that is approved by the EMA and has breakthrough therapy designation in the U.S.

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Pareto Securities' Healthcare Conference: Cinclus Pharma is trying to user in the next generation of acid reflux medicines with, linaprazan glurate, a potassium-competitive acid blocker (P-CAB)

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Pareto Securities' Healthcare Conference: Biotech Analyst Dan Akschuti shares his take on the the conference and the state of biotech, and highlights key companies to watch in the region

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Pareto Securities' Healthcare Conference: Saniona has built expertise in the ion channel space, in addition to its own work, it has partnerships with Jazz, Acadia, and others

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Pareto Securities' Healthcare Conference: BioArctic's CEO Gunilla Osswald highlights the company's brain transporter technology, the latest on Leqembi, and a Parkinson's program

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Pareto Securities' Healthcare Conference: Guard Therapeutics will have a key P2b trial read for its kidney protecting therapy RCM-035 in the 4th quarter - CEO Tobias Agervald walks us through it

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Pareto Securities' Healthcare Conference: BioInvent has recently optimized its pipeline to focus on two key programs - BI-1808, the anti-TNFR2 antibody, and BI-1206, an FcγRIIB inhibitor

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Pareto Securities Healthcare Conference: Basilea is using its financial strength from two marketed products to develop its pipeline and acquire new products - it just received more BARDA funding today

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Takeda's CEO Christophe Weber describes the company's landmark phase 3 data that was presented at World Sleep Congress this week for its first-in-class orexin agonist for treating narcolepsy type 1

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Leaders of Brandon Capital, a seed and VC firm formed in Australia and with an office in the UK as well, discuss their $290 million sixth fund

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Biotech veteran Harvey Berger was named Chairman & CEO of Arena BioWorks today - he describes how 'foraging to focusing' will be the name of the game

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Stevenage, UK based NRG Therapeutics raised a $67M series B today to advance its aim to restore mitochondrial function and slow the progression of neurodegenerative diseases like Parkinson's and ALS

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Fairtility has received FDA clearance on its AI-based embryo assessment tool for IVF, CHLOE Blast, that helps embryologists with embryo and oocyte assessments

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

N-Power Medicine launched what it is calling the 'Industry’s First Prospective External Control Arm Platform' for cancer trials - Mark Lee, CEO and a medical oncologist, explains why and how it works

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Cytokinetics' CEO Robert Blum discusses the result of the MAPLE-HCM study of aficamten, and other learnings from the European Society of Cardiology Congress 2025

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

John Maraganore and Clive Meanwell are launching Corsera Health out of stealth - which, through a combo of predictive diagnostics and an RNAi targeting PCSK9 and angiotensinogen, aims extend lifespans

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

The CEO of Tennr, which raised a $101M series C earlier this summer, explains how the company's platform uses large language models to make the patient referral process to specialists more efficient

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Stanford professor James Zou and his team created a virtual lab with AI scientists - they designed nanobodies for a COVID variant

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

William Blair Senior Biotech Analyst Andy Hsieh reacts to today's oral obesity data from Viking's VK2735 and recent data from Lilly's orforglipron

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Celebrating the 2025 Nucleate Alumni Summit

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

After exiting stealth with $20 million two weeks ago, Orchestra Bio is out to help science entrepreneurs handle the dollars and cents management and long term planning that business requires

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Biotech Direct: MassBio CEO Kendalle Burlin O'Connell and Seaport Therapeutics Founder & CEO Daphne Zohar discuss NIH funding, recent developments at FDA, and improving the public's view of science

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

IO Biotech CEO Mai-Britt Zocca discusses the phase 3 pivotal trial result of the cancer vaccine Cylembio in first line advanced melanoma - and the company's strategy ahead

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Checking in on the progress of CAR-T for autoimmune conditions with the CEO of Kyverna - the company's first (and first for the field) registration intended trial will read in the first half of 2026

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Bay Area based Nosis Bio is leveraging AI to get its gene silencers specifically to precise cell types - it recently announced a development candidate to tackle fibrosis

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Checking in with Alector CEO Arnon Rosenthal ahead of a pivotal trial readout for latozinemab in frontotemporal dementia in the fourth quarter

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

IDEAYA Biosciences is at the forefront of precision oncology - we discuss the pipeline, including a key pivotal trial that will read out for Darovasertib by the end of the year

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

CytomX Therapeutics' years of work on its 'Probody' masking technology may be paying off at a time when there is growing focus on this approach - it presented key initial data on its EpCAM ADC in May

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Maze Therapeutics, which had its IPO earlier this year, is using insights from genetics to develop small molecules - its most advanced program is for a genetic kidney disease

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Astria Therapeutics licensed its HAE treatment, Navenibart, to Kaken Pharmaceutical for the Japanese market. It is a kallikrein inhibitor that is in phase 3, and is dosed up to every six months

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

AI News: While most AI in healthcare is aimed at helping physicians better diagnose and treat disease, CureWise is built for patients to help understand their conditions and ask the right questions

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

From Indianapolis: Serial entrepreneur Derek Small publicly launched a new neuroscience company with $90M earlier this summer, Syndeio Biosciences. He tells us about it and talks Indiana biotech.

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

From Indianapolis: Adipo Therapeutics is approaching the obesity space by trying to turn energy storing 'white' fat into energy burning 'brown' fat

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

The Indiana Biosciences Research Institute is a central hub for the biotech scene in Indiana - its CEO describes what it is all about, and the status of biotech here today

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

BiotechTV visits Indiana University School of Medicine's Stark Neurosciences Research Institute and discusses the latest in Alzheimer's research with its executive director, Bruce Lamb

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Former NIH Director and Co-Founder of ModeX Therapeutics Elias Zerhouni shares his take on possible NIH cuts and the state of science in the United States, and working on multispecifics at his company

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

AI x Bio Summit: Proscia CEO David West describes how AI in pathology is not just helping pathologists find disease, but can also help get the right drug to the right patient

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Monte Rosa Therapeutics' CEO Markus Warmuth updates us on the company's progress in developing molecular glue degraders

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Abivax CEO Marc de Garidel discusses Obefazimod's phase 3 trial result in ulcerative colitis, and what is next for the company

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

AI x Bio Summit: Recursion's Chief R&D Officer & CCO Najat Khan describes how the company leverages AI - including in both the dry lab and the wet lab, and all through clinical trials

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

After receiving a CRL for its RP1 oncolytic immunotherapy yesterday, the CEO of Replimune walks us through the program's timeline and history, and what this might mean for its future

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

AI x Bio Summit: The CEO of Alto Neuroscience, which is working on precision medicine for neuroscience, talks about how the company is using AI and machine learning in its development programs

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

NYSE Strategist Eric Criscuolo shares his take on the markets and biotech sentiment

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

AI x Bio Summit: The Co-Founder and Head of Machine Learning at Dyno Therapeutics describes how his company is using AI to design better capsids

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

RBC's Healthcare Desk Strategist Chris McCarthy discusses biotech sentiment, and positioning around key events and catalysts that are upcoming

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

AI x Bio Summit: Nimbus Therapeutics' new CEO and head of R&D describe how AI is an isn't used in the company's R&D process

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Metsera CEO Whit Bernard shares an update on the company's obesity programs, and comments on the state of the field post ADA

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Cambridge, MA based Avalyn Pharma is developing a novel inhaled formulation of pirfenidone and other medicines for pulmonary fibrosis - it just raised a $100M (up round) series D financing

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

On a visit through London today, NodThera's CEO Dan Swisher discusses the company's brain-penetrant NLRP3 platform, including an asset that's in phase 2 for weight loss

Playlist

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Podcast Details

Information

Listen Show PodCast

Menlo Ventures published a report showing that the healthcare industry is the leading adopter of AI - one of the co-authors shares the key takeaways

Playlist

BIO-Europe 2025: Spain based ARTHEx Biotech is a European player in the DM1 space, and believes its microRNA strategy offers a dual benefit that it says is unique to the field

Playlist

BIO-Europe 2025: Sparrow Pharmaceuticals raised a $95M series B last month - it will be testing its cortisol depleting HSD1 inhibitor in type 2 diabetes

Playlist

BIO-Europe 2025: Topas Therapeutics is delivering nanoparticles to the liver to establish tolerance in T-cells for autoimmune and immune-mediated disease - it recently had intriguing data in celiac

Playlist

BIO-Europe 2025: Step Pharma has 'followed the genetics' to be the first company to target CTPS1 inhibition for cancer - CEO Andrew Parker walks us through this unique science

Playlist

BIO-Europe 2025: Barcelona based Connecta Therapeutics is moving its neuroplasticity modulator for fragile X syndrome into a phase 2a study after completing first in human studies late last year

Playlist

BIO-Europe 2025: Switzerland based ReproNovo is focused on reproductive health - with two clinical stage assets and three indications it is going after

Playlist

BIO-Europe 2025: Anavo Therapeutics is focused on phosphatases - and is publicly talking about its two lead programs for the first time

Playlist

BIO-Europe 2025: Herantis Pharma is developing HER-096 for Parkinson's, a blood-brain-barrier penetrant small peptide molecule that is designed to mimic the activity of CDNF

Playlist

BIO-Europe 2025: Valneva's partner Pfizer has been running a big trial of a Lyme disease vaccine that has covered the last three seasons - it will read out in the first part of next year

Playlist

Roche will pay Manifold Bio $55M up front, and up to $2B in biobucks, to collaborate on multiple next-generation brain shuttles for neurological diseases

Playlist

BIO-Europe 2025: ReNewVax CEO Neil Murray believes the antigens the company has found will enable it to develop a pneumococcal vaccine that targets all ca.100 existing variants

Playlist

BIO-Europe 2025: Abivax CEO Marc de Garidel discusses physician and payor feedback after obefazimod's phase 3 UC induction readouts, and next steps regarding maintenance and Crohn's

Playlist

BIO-Europe 2025: AAVantgarde Bio, which is working on gene therapies for inherited retinal diseases that are caused by mutations in large genes, closed a $141M series B raise today

Playlist

Mathai Mammen recaps the first clinical data Parabilis Medicines reported on its beta-catenin program earlier this month at EMSO and AACR-NCI-EORTC 2025. Plus, degraders for prostate cancer, and more.

Playlist

BiotechTV visited South San Francisco based Noetik and saw how they are digitizing tumor samples and using AI to sort through the complexity of the biology for drug discovery

Playlist

Sonoma Biotherapeutics announced early clinical data today in a late-breaker at #ACR25 for its CAR-Treg to treat rheumatoid arthritis. Co-Founders Jeff Bluestone and Fred Ramsdell walk us through it.

Playlist

Zag Bio launched today with $80M, and aims to tackle autoimmune disease by using antibodies to reprogram how Tregs and Teffs are created in the thymus. The lead indication will be Type 1 diabetes

Playlist

Hemab Therapeutics, a company specializing in developing treatments for bleeding disorders, announced a $157 million series C raise today. CEO Benny Sorensen describes the work and unmet need.

Playlist

Weave Bio, which raised a $20M series A this month, is aiming to use software and LLMs to automate and streamline regulatory submissions for drug development

Playlist

Ahead of a year of increased clinical activity, Entrada Therapeutics' CEO Dipal Doshi discusses the company's EEV platform, DMD programs, and a Vertex partnership in DM1

Playlist

Disc Medicine CEO John Quisel describes the process of becoming among the first companies to receive FDA's new Commissioner's National Priority Voucher (CNPV)

Playlist

Biotech entrepreneurs share advice on navigating through today's uncertain times: "It's going to be okay"

Playlist

Flagship Pioneering announced its newest company to emerge out of stealth mode today: Expedition Medicines. It is leveraging generative design for small molecule covalent chemistry

Playlist

Biotech veteran Oz Azam has become the CEO of Cue Biopharma. He walks us through the science behind the company's new focus in autoimmune that has him excited about the opportunity

Playlist

Get to know Women In Bio, and how this organization helps women at all stages of their careers in biotech

Playlist

Emeryville, CA based Profusa is developing an injectable biosensor that aims to generate biochemistry information for users in real time

Playlist

PepGen's CEO James McArthur gives an overview of the company's recent data in myotonic dystrophy type 1, which showed a mean splicing correction of 53.7% at the 15 mg/kg dose

Playlist

Benchtalk 2025: Kate Haviland discusses the $9B+ acquisition of Blueprint by Sanofi, being chair of Fulcrum, her thoughts on M&A, and what is interesting in biotech today

Playlist

Benchtalk 2025: Generate:Biomedicines' VP of Informatics Stephen Kottmann describes the investments in technology that ensures only the highest quality data returns back into its models

Playlist

Benchtalk 2025: Benchling Co-Founder & CEO Sajith Wickramasekara describes why he believes science and Benchling are entering a new era of speed and cost of R&D

Playlist

Benchtalk 2025: Dyne Therapeutics' CSO Ron Batra describes the company's FORCE platform, and previews big trial scheduled in DMD and DM1 over the next year

Playlist

Sunrise Group, which has designed a mandibular sensor for at-home diagnosis of sleep apnea, recently raised $29M to expand its digital sleep clinic that patients can access remotely

Playlist

Oxford's OrganOx became one of the UK's biggest news stories when it was announced it would be acquired by Japan's Terumo for approximately $1.5 billion - here's the revolutionary technology behind it

Playlist

Oxford, UK based OMass Therapeutics, experts in the use of mass spectrometry in drug development, recently landed a $20M up front licensing deal with Roche on one of its preclinical candidates for IBF

Playlist

NYSE Market Strategist Eric Criscuolo discusses biotech's newfound momentum and whether it might attract generalists to take a look at the sector

Playlist

Immuneering's CEO walks us through the company's MEK data in pancreatic cancer, and explains the science behind 'deep cyclic inhibition'

Playlist

R.W. Baird Managing Director & Senior Biotech Analyst Brian Skorney discusses numerous battleground companies in biotech

Playlist

Biotech veteran David Hung talks about the launch of IBTROZI in ROS1 positive non-small cell lung cancer, and what's next for Nuvation Bio